Edition:
United States

Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)

600566.SS on Shanghai Stock Exchange

32.95CNY
24 Mar 2017
Change (% chg)

¥-0.15 (-0.45%)
Prev Close
¥33.10
Open
¥33.07
Day's High
¥33.30
Day's Low
¥32.80
Volume
2,250,557
Avg. Vol
2,725,398
52-wk High
¥35.66
52-wk Low
¥22.00

Latest Key Developments (Source: Significant Developments)

Hubei Jumpcan Pharmaceutical names new chairman, general manger and CFO
Monday, 6 Mar 2017 12:20am EST 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS> :Says it appoints Cao Longxiang as new chairman of the board and general manager, and Wu Hongliang as CFO.  Full Article

Hubei Jumpcan Pharma's prelim 2016 profit rises 35.8 pct y/y
Monday, 6 Feb 2017 05:49am EST 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS> :Says prelim 2016 net profit up 35.8 percent y/y at 932.46 million yuan ($135.91 million).  Full Article

Hubei Jumpcan Pharmaceutical unit gets GMP certificate
Friday, 25 Nov 2016 04:01am EST 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>: Says its unit received goods manufacture practice (GMP) certificate from Jiangsu Food and Drug Administration Bureau .Says certificate issued to agent mixture, oral solution and mucilage manufactured by the unit and the valid period is until Nov. 20, 2021.  Full Article

Hubei Jumpcan Pharmaceutical says controlling shareholder transfers 12.4 pct stake in the co
Friday, 25 Nov 2016 04:00am EST 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS>:Says its controlling shareholder has transferred 100 million shares (12.4 percent stake) of the co to the controlling shareholder's wholly owned subsidiary.  Full Article

Hubei Jumpcan Pharma's H1 net profit up 33 pct
Monday, 8 Aug 2016 07:03am EDT 

Hubei Jumpcan Pharmaceutical Co Ltd <600566.SS> :Says H1 net profit up 33.0 percent y/y at 440.4 million yuan ($66.12 million).  Full Article

Hubei Jumpcan Pharmaceutical unit gets approval for drug clinic trial
Monday, 11 Jul 2016 01:06am EDT 

Hubei Jumpcan Pharmaceutical <600566.SS> Co., Ltd:Says it unit receives drug clinic trial approval from China Food and Drug Administration, for levetiracetam injection.  Full Article

Hubei Jumpcan Pharmaceutical completes private placement of 642.3 mln yuan
Monday, 16 May 2016 02:08am EDT 

Hubei Jumpcan Pharmaceutical Co., Ltd. <600566.SS> :Says it completes the issue of 28.2 million A shares at 22.8 yuan per share, for 642.3 million yuan via private placement to seven companies.  Full Article

HUBEI JUMPCAN PHARMACEUTICAL amends private placement plan
Wednesday, 20 Apr 2016 08:00pm EDT 

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD:Revises private placement plan, which is previously updated on June 30.Revises issue price to 19.59 yuan per share instead of 20.29 yuan per share.  Full Article

HUBEI JUMPCAN PHARMACEUTICAL announces 2015 dividend payment date
Wednesday, 13 Apr 2016 08:00pm EDT 

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD:To pay cash dividend of 0.7 yuan per 10 shares (before tax) to shareholders for 2015 as a record of April 19.The company's shares will be traded ex-right and ex-dividend on April 20 and the dividend will be paid on April 20.  Full Article

HUBEI JUMPCAN PHARMACEUTICAL says 2015 dividend payment as 0.7 yuan per share
Friday, 18 Mar 2016 08:00pm EDT 

HUBEI JUMPCAN PHARMACEUTICAL CO., LTD:To pay cash dividend of 7 yuan per 10 shares (before tax) to the company's shareholders for 2015.  Full Article

More From Around the Web

BRIEF-Hubei Jumpcan Pharmaceutical names new chairman, general manger and CFO

* Says it appoints Cao Longxiang as new chairman of the board and general manager, and Wu Hongliang as CFO